닥플 플러스
2026 International Congress of Diabetes and Metabolism(1일차)
대한당뇨병학회
연수평점 :2점
오프라인
주관
대한당뇨병학회
교육일자
2026-10-15
수강료
450,000원
교육형태
오프라인
등록일시
2026-08-06
교육시간
15시간
연수평점
2점
장소
서울특별시 서울, 마곡코엑스(1층, 3층, 4층)
교육종류
내과
타임테이블
| 날짜 | 시간 | 강의명 | 강사 | 구분 |
|---|---|---|---|---|
| 2026-10-15 | 14:30~14:45 | Telemedicine regulation in Korea: principles and directions | 권용진(서울의대 서울대병원) | - |
| 2026-10-15 | 14:45~15:00 | Safety concerns in telemedicine and the role of KDA practice standards | 김진숙(대한의사협회 의료정책연구원) | - |
| 2026-10-15 | 15:00~15:15 | Structuring telemedicine guidance for diabetes: an endocrinologist | 김헌성(가톨릭의대 내과) | - |
| 2026-10-15 | 15:15~15:30 | Panel discussion | 한정훈 선재원 백종하 김명진(대구프렌닥터한내과의원 나만의닥터 경상의대 내과 한림의대 내과) | - |
| 2026-10-15 | 14:30~14:50 | Establishing pancreatic endocrine dysfunction as an internal organ disability: background and criteria | 김재현(서울의대 소아청소년과) | - |
| 2026-10-15 | 14:50~15:10 | Quality of life and social challenges following registration as a person with a disability | 김경미(숭실대 사회복지학과) | - |
| 2026-10-15 | 15:10~15:30 | Panel discussion | 박유정 김준영(안산대 사회복지학과 한림대의료원 동탄성심병원) | - |
| 2026-10-15 | 14:30~15:00 | Heterogeneity of clinical-pathological trajectories in DKD | 문주영(경희의대) | - |
| 2026-10-15 | 15:00~15:30 | Decoding DKD heterogeneity: clinical pharmacological approaches to bridge renal injury and long-term outcomes | Hiddo Lambers Heerspink(University Medical Center Groningen) | - |
| 2026-10-15 | 14:30~14:50 | Plasma and extracellular vesicle multi-omics responses to single bout of resistance and endurance exercise in humans | 이현승(충남의대 내과) | - |
| 2026-10-15 | 14:50~15:10 | Aging reshapes sex- and diet-specific metabolic plasticity across the adipose–liver–muscle axis | 오창명(GIST ) | - |
| 2026-10-15 | 15:10~15:30 | Spatially resolved metabolic flux modeling of liver tissue: integrating transcriptomics, metabolomics, and metallomics via genome-scale constraint-based modeling | Cheng Zhang(KCL UK) | - |
| 2026-10-15 | 14:30~14:45 | Metabolic aging and insulin resistance: mechanistic overlap in older adults | 최종한(건국의대 내과) | - |
| 2026-10-15 | 14:45~15:00 | Sarcopenia and type 2 diabetes in older adults: pathophysiological mechanisms and therapeutic strategies | 정혜수(한림의대 내과) | - |
| 2026-10-15 | 15:00~15:15 | Chronic kidney disease in older adults with diabetes: clinical and pathophysiological perspectives | 노은(서울의대 내과) | - |
| 2026-10-15 | 15:15~15:30 | Panel discussion | 전성완 유성훈 배재현(포항세명기독병원 내과 한양의대 내과 한림의대 내과) | - |
| 2026-10-15 | 15:30~15:40 | 휴식 | - | - |
| 2026-10-15 | 15:40~16:00 | Updates in CGM interpretation: from core metrics and AGP to GMI–A1C discordance | 진상만(성균관의대 내과) | - |
| 2026-10-15 | 16:00~16:20 | Results from the first clinical trial of a stage 5 connected insulin pen | 김지윤(성균관의대 내과) | - |
| 2026-10-15 | 16:20~16:40 | Pathways to fully automated insulin delivery: scientific feasibility and remaining barriers | John Shin(MiniMed) | - |
| 2026-10-15 | 15:40~16:00 | Noninvasive imaging for MASLD: from transient elastography to magnetic resonance imaging | Wah-Kheong Chan(University of Malaya) | - |
| 2026-10-15 | 16:00~16:20 | Blood-based biomarkers and scores: practical approaches to fibrosis assessment | 이혜원(연세의대 내과) | - |
| 2026-10-15 | 16:20~16:40 | Future directions in MASLD diagnostics: AI, radiomics, and multi-omics approaches | Terry Cheuk Yip(The Chinese University of Hong Kong) | - |
| 2026-10-15 | 15:40~16:00 | Compensatory signatures of β-cells and islet stellate cells in human obesity | 김현기(KAIST) | - |
| 2026-10-15 | 16:00~16:20 | An unbiased drug screen to identify agents that reverse β-cell dedifferentiation | Jinsook Son(Cornell University) | - |
| 2026-10-15 | 16:20~16:40 | Impact of type 2 diabetes-associated PAX4 variant on pancreatic beta cell function | 문준호(서울의대 내과) | - |
| 2026-10-15 | 15:40~15:55 | Microvascular angiopathy and mitochondrial dysfunction: the pivotal drivers of diabetic nerve damage and therapeutic targets | 김수경(경상의대 내과) | - |
| 2026-10-15 | 15:55~16:10 | The search for biomarkers for early prediction of diabetic peripheral neuropathy | 조호찬(계명의대 내과) | - |
| 2026-10-15 | 16:10~16:25 | Epigenetic regulation of diabetic neuropathy | Ji Hu(Soochow University) | - |
| 2026-10-15 | 16:25~16:40 | Panel discussion | 김지민 이경애 김종화(세종충남대병원 전북의대 내과 부천세종병원 내과) | - |
| 2026-10-15 | 15:40~16:00 | Impact of GDM on mother and offspring | Ronald Ma(The Chinese University of Hong Kong) | - |
| 2026-10-15 | 16:00~16:20 | Early GDM consensus statement | Viswanathan Mohan(Madras Diabetes Research Foundation) | - |
| 2026-10-15 | 16:20~16:40 | The emerging role of CGM in gestational diabetes: evidence and future directions | 최훈지(동탄성심병원) | - |
| 2026-10-15 | 16:40~16:50 | 휴식 | - | - |
| 2026-10-15 | 16:50~17:05 | Early initiation of CGM and AID in T1D | Viral N Shah(Indiana University) | - |
| 2026-10-15 | 17:05~17:20 | The gap beyond the AGP: translating patterns into prescribing decisions in T2D and prediabetes | 유승현(가톨릭관동의대 내과) | - |
| 2026-10-15 | 17:20~17:35 | Diabetes technology from a patient | Noriko Kodani(National Center for Global Health and Medicine) | - |
| 2026-10-15 | 17:35~17:50 | Panel discussion | 양여리 문선준 홍준화(가톨릭의대 내과 성균관의대 내과 을지의대 내과) | - |
| 2026-10-15 | 16:50~17:05 | The efficacy and safety of CU01-1001 in subjects with diabetic kidney disease (DKD) | 원규장(영남의대 내과) | - |
| 2026-10-15 | 17:05~17:20 | Vanoglipel, the most advanced GPR119 agonist for MASH | 김미경(동아ST) | - |
| 2026-10-15 | 17:20~17:35 | Targeting hepatic enzymes as a strategy to suppress MASH | 송재환(연세대 생화학과) | - |
| 2026-10-15 | 17:35~17:50 | Panel discussion | 임승순 김주연 하은영(계명의대 생리학교실 한양대 에리카 분자의약 계명의대 내과) | - |
| 2026-10-15 | 16:50~17:10 | NT-proBNP as a biomarker of cardiometabolic risk: global evidence and emerging perspectives | Ronald Ma(The Chinese University of Hong Kong) | - |
| 2026-10-15 | 17:10~17:30 | Integrating NT-proBNP into diabetes care: implications for cardio-renal protection strategies | 전자영(아주의대 내과) | - |
| 2026-10-15 | 17:30~17:50 | NT-proBNP in the early detection and management of heart failure in patients with type 2 diabetes | 조동혁(고려의대 심장내과) | - |
| 2026-10-15 | 16:50~17:10 | Genetic basis of type 1 diabetes and utility of genetic risk scores across diverse genetic ancestries | Stephen S. Rich(University of Virginia) | - |
| 2026-10-15 | 17:10~17:30 | Polygenic risk scores and heterogeneity of metabolic disease | 김대은(서울의대) | - |
| 2026-10-15 | 17:30~17:50 | Biobank studies for diabetes in East Asia | Wayne H-H Sheu(National Health Research Institutes) | - |
| 2026-10-15 | 16:50~17:10 | From cohort to national infrastructure: multi-center CDM-based AI for predicting diabetic complications | 이상열(경희의대 내과) | - |
| 2026-10-15 | 17:10~17:30 | Reshaping diabetes care with AI prognostic management and prescription digital therapeutics | 황보율(국립암센터) | - |
| 2026-10-15 | 17:30~17:50 | Panel discussion | 이승희 차효성 임유리 박태현(국립보건연구원 위뉴 에비드넷 오디엔) | - |
비고
Early bird 등록(2026년 8월 10일까지): 전문의(KDA 회원 240,000원 / 비회원 300,000원), 전공의·간호사·영양사·사회복지사·약사·연구원·운동처방사·관련 분야 교수 및 기타(KDA 회원 140,000원 / 비회원 200,000원)Advance 등록(2026년 9월 11일까지): 전문의(KDA 회원 280,000원 / 비회원 350,000원), 전공의 등(KDA 회원 180,000원 / 비회원 230,000원)현장등록(2026년 10월 15일~17일): 전문의(KDA 회원 370,000원 / 비회원 450,000원), 전공의 등(KDA 회원 250,000원 / 비회원 270,000원)
문의처
담당자
이연주
연락처
02-714-9071
이메일
diabetes@kams.or.kr